Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: Comparison with antidepressant drugs

被引：57
作者：
Gobbi, G
Blier, P
机构：
[1] Univ Montreal, Dept Psychiat, Montreal, PQ H3A 1A1, Canada
[2] McGill Univ, Montreal, PQ H3A 1A1, Canada
[3] Univ Ottawa, Royal Ottawa Hosp, Mental Hlth Res Inst, Ottawa, ON K1Z 7K4, Canada
来源：
PEPTIDES | 2005年 / 26卷 / 08期
关键词：
antidepressant; anxiolytic; substance P; antagonist of SP; NK1; receptor; depression; anxiety;
D O I：
10.1016/j.peptides.2005.03.032
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Neurokinin-1 (NK1) receptor antagonists have been reported to possess antidepressant and anxiolytic properties in controlled trials. Since antidepressant and anxiolytic drugs act mainly by enhancing serotonin (5-HT) and norepinephrine (NE) neurotransmission in forebrain areas, the main focus of the present review is to critically examine the electrophysiological effects of NK1 receptor antagonists on serotoninergic and noradrenergic neurons, and then hippocampal neurons. It is concluded that NK1 antagonists increase the firing and burst activity of 5-HT neurons, increase burst activity of NE neurons, and modulate postsynaptic transmission at the hippocampus level. Further research is needed in order to develop more selective ligands for the human NK1 receptor and to gain better knowledge of required brain penetration and optimal pharmacodynamic conditions for their use in patients. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码：1383 / 1393
页数：11
相关论文
共 84 条
  • [11] Substance P (NK1) receptors in the cingulate carter in unipolar and bipolar mood disorder and schizophrenia
    Burnet, PWJ
    Harrison, PJ
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 47 (01) : 80 - 83
  • [12] CARPENTER LL, 2003, 42 M AM COLL NEUR AC, P71
  • [13] CHAPUT Y, 1991, NEUROPSYCHOPHARMACOL, V5, P219
  • [14] Noradrenergic neurons expressing substance P receptor (NK1) in the locus coeruleus complex: a double immunofluorescence study in the rat
    Chen, LW
    Wei, LC
    Liu, HL
    Rao, ZR
    [J]. BRAIN RESEARCH, 2000, 873 (01) : 155 - 159
  • [15] Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus
    Commons, KG
    Valentino, RJ
    [J]. JOURNAL OF COMPARATIVE NEUROLOGY, 2002, 447 (01) : 82 - 97
  • [16] Substance P (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity
    Conley, RK
    Cumberbatch, MJ
    Mason, GS
    Williamson, DJ
    Harrison, T
    Locker, K
    Swain, C
    Maubach, K
    O'Donnell, R
    Rigby, M
    Hewson, L
    Smith, D
    Rupniak, NMJ
    [J]. JOURNAL OF NEUROSCIENCE, 2002, 22 (17) : 7730 - 7736
  • [17] Culman J, 1997, J PHARMACOL EXP THER, V280, P238
  • [18] PHARMACOLOGICAL CHARACTERIZATION AND AUTORADIOGRAPHIC LOCALIZATION OF SUBSTANCE-P RECEPTORS IN GUINEA-PIG BRAIN
    DAM, TV
    QUIRION, R
    [J]. PEPTIDES, 1986, 7 (05) : 855 - 864
  • [19] DEMONTIGNY C, 1984, J PHARMACOL EXP THER, V228, P230
  • [20] Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment
    Dong, J
    Blier, P
    [J]. PSYCHOPHARMACOLOGY, 2001, 155 (01) : 52 - 57
123456789